This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jul 16;378(9787):201-3.

doi: 10.1016/S0140-6736(11)60992-6.

Rilpivirine: a step forward in tailored HIV treatment

Rik Schrijvers¹, Belete Ayele Desimmie, Zeger Debyser

Affiliations

PMID: 21763920
DOI: 10.1016/S0140-6736(11)60992-6

Comment

Rilpivirine: a step forward in tailored HIV treatment

Rik Schrijvers et al. Lancet. 2011.

. 2011 Jul 16;378(9787):201-3.

doi: 10.1016/S0140-6736(11)60992-6.

Authors

Rik Schrijvers¹, Belete Ayele Desimmie, Zeger Debyser

Affiliation

¹ Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.

PMID: 21763920
DOI: 10.1016/S0140-6736(11)60992-6

No abstract available

PubMed Disclaimer

Comment on

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.
Cohen CJ, Andrade-Villanueva J, Clotet B, Fourie J, Johnson MA, Ruxrungtham K, Wu H, Zorrilla C, Crauwels H, Rimsky LT, Vanveggel S, Boven K; THRIVE study group. Cohen CJ, et al. Lancet. 2011 Jul 16;378(9787):229-37. doi: 10.1016/S0140-6736(11)60983-5. Lancet. 2011. PMID: 21763935 Clinical Trial.
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.
Molina JM, Cahn P, Grinsztejn B, Lazzarin A, Mills A, Saag M, Supparatpinyo K, Walmsley S, Crauwels H, Rimsky LT, Vanveggel S, Boven K; ECHO study group. Molina JM, et al. Lancet. 2011 Jul 16;378(9787):238-46. doi: 10.1016/S0140-6736(11)60936-7. Lancet. 2011. PMID: 21763936 Clinical Trial.

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information